Intestinal Barrier Dysfunction in Inflammatory Bowel Disease: Underpinning Pathogenesis and Therapeutics

Area of Science:

• Gastroenterology
• Immunology
• Cell Biology

Background:

• The intestinal barrier, comprising luminal enzymes, bile acids, and epithelial layers, maintains gut homeostasis.
• It regulates the interface between luminal contents (food, microbes) and the gastrointestinal tract.
• Barrier dysfunction is increasingly recognized in chronic inflammatory gastrointestinal conditions.

Purpose of the Study:

• To review the role of intestinal barrier dysfunction in inflammatory bowel disease (IBD) pathogenesis.
• To examine the pathophysiology of increased intestinal permeability in IBD.
• To explore potential therapeutic targets and clinical applications for IBD.

Main Methods:

• Literature review of studies on intestinal barrier function and IBD.
• Analysis of mechanisms underlying increased intestinal permeability in IBD.
• Identification of potential therapeutic strategies targeting barrier repair and integrity.

Main Results:

• Barrier dysfunction is a key factor in IBD development and progression.
• Specific molecular pathways contribute to heightened intestinal permeability in IBD.
• Several targets show promise for therapeutic intervention.

Conclusions:

• Restoring intestinal barrier integrity is a viable therapeutic strategy for IBD.
• Further research into specific targets could lead to novel IBD treatments.
• Targeting barrier dysfunction offers a new avenue for managing inflammatory bowel disease.